If you haven’t yet subscribed to any of the major streaming services, first I have to ask: How have you avoided them? Second: You’ve missed the boat when it comes to trying the biggest names for free.
Streaming giant Netflix quietly did away with its 30-day trial in the U.S., according to CNET, just like Disney+, which stopped offering free trials back in June. The U.S. is not the only market where Netflix has decided to end its free trial. The company ended trial periods in Mexico and several other countries as far back as two years ago.
“Free trials are not available, but you can still sign up and take advantage of all Netflix has to offer,” Netflix’s free trial help page now reads. In a statement to CNET, a Netflix spokesperson said the company is currently looking at
Apple TV+ is nearing the end of its free trial period
However, Apple has decided to extend Apple TV+’s free trial period through February next year
This can entice more consumers to try out the streaming service
Apple launched Apple TV+ last year alongside the iPhone 11 series. At the time, the Cupertino tech giant said it will offer one free year of Apple TV+ to those who will buy new devices. Those who did buy new iPhones were able to enjoy the company’s TV offerings without having to pay a cent.
The free trial period is almost nearing its end, but Apple told TechCrunch that it is extending the free subscription period by a few more months and will bill subscribers starting February 2021.
The report said the extension includes everyone whose Apple TV+ free trials are set to end on Nov. 1, 2020, through Jan. 31,
Apple will extend some Apple TV+ subscriptions on a free one-year trial through February, the company confirmed to CNBC on Thursday.
When Apple TV+ launched last fall, Apple bundled a free one-year subscription with the purchase of an Apple product, and the first of those trial subscriptions were previously going to expire at the start of November.
Someone who signed up for a free year of Apple TV+ on the 25th of January, for example, will have access and won’t be billed until February 25.
Jabil Inc. (NYSE: JBL) today announced that its Photonics business unit, a leading provider of customized end-to-end design, manufacturing and test solutions for optical communications products, successfully completed live network trials for the application of 100G in unamplified metro regional link scenarios.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201001005092/en/
Jabil Photonics CFP2 Digital Coherent Optics (DCO) 100G/200G Module (Photo: Business Wire)
Powered by Jabil Photonics’ GA CFP2 Digital Coherent Optics (DCO) 100G/200G module, the first network scenario showcased an unamplified metro Wavelength-Division Multiplexing (WDM) point-to-point link with 8 channels at 100Gb/s rate with the module achieving a 32dB error-free link (approximately 130Km single mode fiber) using the 100G Quadrature Phase Shift Keying (QPSK) with Soft-Decision Forward Error Correction (SD-FEC) mode enablement.
The second network scenario for the same CFP2 DCO module involved a single channel 100Gb/s application reaching a 38dB 100G error-free link (more than 150Km
Trials of a hydrogen-powered train are underway in the U.K. with an initial journey successfully completed between the locations of Long Marston and Evesham in the West Midlands region of England.
The HydroFLEX train — which has been developed by a team from the University of Birmingham and Porterbrook, a rolling stock firm — uses a fuel-cell which combines hydrogen and oxygen to generate electricity, heat and water.
The train has been fitted with a range of kit inside one of its carriages. This tech includes a hydrogen fuel tank, the aforementioned fuel-cell and lithium ion batteries for storage. It’s hoped that the technology will be available to retrofit trains already in use by the year 2023.
A statement issued Wednesday, published on the website of both the University of Birmingham and U.K. government, said the university was also, “developing a hydrogen and battery powered
AstraZeneca’s late-stage coronavirus vaccine trial in the U.S. remains on hold as federal investigators seek “answers to important questions” over its safety for patients, Health and Human Services Secretary Alex Azar told CNBC on Wednesday.
Global clinical trials for AstraZeneca’s Covid-19 vaccine, called AZD1222, were placed on hold Sept. 6 after one of the participants in the U.K. reported a serious adverse reaction. Following an investigation, AstraZeneca said on Sept. 12 that it had resumed trials in the U.K., though the U.S. trial has since remained on hold.
“Look at the AstraZeneca program, phase three clinical trial, a lot of hope. Single serious adverse event report in the United Kingdom, global shutdown and hold of the clinical trials,” Azar told CNBC’s “Squawk Box” in defense of the Trump administration’s quick development of a Covid-19 vaccine amid safety concerns.
“Still on hold here in the United States as the (U.S. Food